Martine Rothblatt

2013

In 2013, Martine Rothblatt earned a total compensation of $38.2M as Chairman and Co-Chief Executive Officer at United Therapeutics, a 380% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,102,907
Option Awards$36,097,326
Salary$992,678
Other$25,344
Total$38,218,255

Rothblatt received $36.1M in option awards, accounting for 94.45% of the total pay in 2013.

Rothblatt also received $1.1M in non-equity incentive plan, $992.7K in salary and $25.3K in other compensation.

Rankings

In 2013, Martine Rothblatt's compensation ranked 20th out of 12,215 executives tracked by ExecPay. In other words, Rothblatt earned more than 99.8% of executives.

ClassificationRankingPercentile
All
20
out of 12,215
100th
Division
Manufacturing
4
out of 4,595
100th
Major group
Chemicals And Allied Products
1
out of 1,425
100th
Industry group
Drugs
1
out of 1,126
100th
Industry
Pharmaceutical Preparations
1
out of 869
100th
Source: SEC filing on April 28, 2016.

Rothblatt's colleagues

We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2013.

2013

Roger Jeffs

United Therapeutics

Chief Executive Officer

2013

John Ferrari

United Therapeutics

Chief Financial Officer

2013

Paul Mahon

United Therapeutics

General Counsel

News

In-depth

You may also like